UK Head Office
+44(0)1494 771734
or Buy Now! online

Hot Reports:
Brazil Healthcare - New Opportunities for Growth


US Non-Invasive Prenatal Diagnostics - Market Insight


Global Genetic Testing Market Forecast to 2015


US Clinical Laboratory Testing Market Assessment


US Cardiac Device Market Analysis


Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022


In Vitro Diagnostics: World Market Outlook 2012-2022


Pharma Wholesale and Distribution Market: World Outlook 2012-2022

Table of Contents

Market Study
Published: June 2012
Pages: 116
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 0.00  Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Health Products

Why the smoking treatment market can grow - discover its potential now

What are the commercial prospects for anti-smoking treatments? Visiongain's report shows you potential revenues and trends to 2022, discussing data, opportunities and prospects.

Our investigation gives you business research and analysis with sales forecasts. It lets you assess forecasted sales at world market, submarket, product and national level to 2022.

You find analysis of prescription (Rx) and over-the-counter (OTC) therapies for smoking. How will leading products - including Nicorette, Nicotinell and Champix/Chantix - perform from 2012? Our report gives predictions and discussions of sales potential.

Also, you see forecasting of therapeutic categories to 2022, finding potential revenues:
• Over-the-counter (OTC) smoking cessation products
• Prescription (Rx) drugs
• Nicotine replacement therapy (NRT)
• Nicotine receptor partial agonists
• Antidepressant therapy segment.

Our study lets you assess the anti-smoking R&D pipeline too, seeing trends and opportunity. You find discussions of treatments in development:
• Nicotine vaccines
• Monoamine oxidase inhibitors
• Cannabinoid receptor-1 antagonists
• Dopamine D3 antagonists
• Opiate antagonists
• Other agents for smoking therapy.

What does the future hold? From 2012 to 2022, the pharmaceutical industry will improve treatments for smoking cessation, with our report predicting revenue growth. R&D is promising. New formulations and generics will be important too.

Innovations in drug delivery and rising demand in developing countries will also stimulate the industry and market. The study shows you technological and commercial possibilities.

What about leading companies? Our work discusses Pfizer, GSK, Novartis and other players. You see where companies are heading from 2012.

You can investigate the future of medicine for smoking cessation now, finding revenue potentials and other trends.

Sales forecasts, market shares, developmental trends and discussions

In visiongain's report you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses (SWOT and STEP) and discussion of R&D activities. You receive 34 tables, 29 charts and three research interviews.

Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you

In particular, our study gives you the following knowledge on the topic:
• Find potential revenues to 2022 for the world market and submarkets
• Discover projected revenue trends of leading products to 2022
• See market forecasting to 2022 for the US, Japan, EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends by therapeutic area
• Investigate competition and opportunities influencing sales
• Find out what will stimulate and restrain the industry and market
• View opinion from our survey, seeing interviews with authorities.

There, you find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed on business intelligence.

Top of Page